Raloxifene and endothelial function in healthy postmenopausal women.

Objective: The purpose of this study was to determine the effects of raloxifene on endothelial function in healthy, postmenopausal women.

Study Design: This was a randomized, double-blind, placebo-controlled crossover trial. Subjects (n = 19; mean age, 61 years) underwent endothelial function testing at baseline and after treatment with placebo or raloxifene (60 mg per day for 6 weeks).